Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-catechin | multiple interactions | ISO | TSPAN13 (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of TSPAN13 mRNA | CTD | PMID:24763279 | 1,2-dichloroethane | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of TSPAN13 mRNA | CTD | PMID:28960355 | 1,2-dimethylhydrazine | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of TSPAN13 mRNA | CTD | PMID:22206623 | 1,2-dimethylhydrazine | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of TSPAN13 mRNA | CTD | PMID:22206623 | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:27291303 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of TSPAN13 mRNA | CTD | PMID:19770486 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TSPAN13 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Tspan13 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of TSPAN13 mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of TSPAN13 mRNA | CTD | PMID:19465110 and PMID:19933214 | 3,3',5,5'-tetrabromobisphenol A | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | tetrabromobisphenol A results in decreased expression of TSPAN13 mRNA | CTD | PMID:25172293 | 4-hydroxyphenyl retinamide | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Fenretinide results in increased expression of TSPAN13 mRNA | CTD | PMID:28973697 | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of TSPAN13 mRNA | CTD | PMID:30047161 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of TSPAN13 mRNA | CTD | PMID:31881176 | aflatoxin B1 | increases methylation | ISO | TSPAN13 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of TSPAN13 gene | CTD | PMID:27153756 | all-trans-retinoic acid | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of TSPAN13 mRNA | CTD | PMID:21934132 | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of TSPAN13 mRNA | CTD | PMID:30047161 | aristolochic acid A | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of TSPAN13 mRNA | CTD | PMID:33212167 | arsane | affects methylation | ISO | TSPAN13 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TSPAN13 gene | CTD | PMID:25304211 | arsenic atom | affects methylation | ISO | TSPAN13 (Homo sapiens) | 6480464 | Arsenic affects the methylation of TSPAN13 gene | CTD | PMID:25304211 | benzo[a]pyrene | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of TSPAN13 mRNA | CTD | PMID:23735875 | benzo[a]pyrene | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of TSPAN13 mRNA | CTD | PMID:32417428 | Benzo[k]fluoranthene | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | benzo(k)fluoranthene results in increased expression of TSPAN13 mRNA | CTD | PMID:26377693 | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of TSPAN13 mRNA | CTD | PMID:25181051 | bisphenol A | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of TSPAN13 mRNA | CTD | PMID:29275510 and PMID:33670352 | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of TSPAN13 mRNA | CTD | PMID:25993096 | carbamazepine | affects expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of TSPAN13 mRNA | CTD | PMID:25979313 | carbon nanotube | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | choline | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSPAN13 mRNA | CTD | PMID:20938992 | cisplatin | multiple interactions | ISO | TSPAN13 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in decreased expression of TSPAN13 mRNA | CTD | PMID:27392435 | clobetasol | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Clobetasol results in increased expression of TSPAN13 mRNA | CTD | PMID:27462272 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of TSPAN13 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of TSPAN13 mRNA | CTD | PMID:30556269 | copper(II) sulfate | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Copper Sulfate results in increased expression of TSPAN13 mRNA | CTD | PMID:18579281 | Cuprizon | decreases expression | EXP | | 6480464 | Cuprizone results in decreased expression of TSPAN13 mRNA | CTD | PMID:26577399 | cyclosporin A | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of TSPAN13 mRNA | CTD | PMID:27989131 | decabromodiphenyl ether | increases expression | EXP | | 6480464 | decabromobiphenyl ether results in increased expression of TSPAN13 mRNA | CTD | PMID:23640034 | dibenz[a,h]anthracene | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dibenzo[a,l]pyrene | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | dibenzo(a and l)pyrene results in increased expression of TSPAN13 mRNA | CTD | PMID:25908611 | dicrotophos | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | dicrotophos results in decreased expression of TSPAN13 mRNA | CTD | PMID:28302478 | diethylstilbestrol | decreases expression | EXP | | 6480464 | Diethylstilbestrol results in decreased expression of TSPAN13 mRNA | CTD | PMID:36653537 | dioxygen | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of TSPAN13 mRNA | CTD | PMID:30529165 | diquat | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Diquat results in decreased expression of TSPAN13 mRNA | CTD | PMID:36851058 | dorsomorphin | multiple interactions | ISO | TSPAN13 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN13 mRNA | CTD | PMID:27188386 | doxorubicin | affects response to substance | ISO | TSPAN13 (Homo sapiens) | 6480464 | TSPAN13 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | doxorubicin | affects expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of TSPAN13 mRNA | CTD | PMID:29803840 | ethanol | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | Ethanol affects the expression of and affects the splicing of TSPAN13 mRNA | CTD | PMID:30319688 | folic acid | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [1 more ... | CTD | PMID:20938992 and PMID:22206623 | folic acid | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of TSPAN13 mRNA | CTD | PMID:25629700 | furan | increases expression | EXP | | 6480464 | furan results in increased expression of TSPAN13 mRNA | CTD | PMID:27387713 | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of TSPAN13 mRNA | CTD | PMID:33387578 | L-methionine | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of TSPAN13 mRNA | CTD | PMID:20938992 | lead diacetate | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | lead acetate results in increased expression of TSPAN13 mRNA | CTD | PMID:21829687 | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of TSPAN13 mRNA | CTD | PMID:30047161 | methylisothiazolinone | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | 2-methyl-4-isothiazolin-3-one results in increased expression of TSPAN13 mRNA | CTD | PMID:31629900 | okadaic acid | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Okadaic Acid results in increased expression of TSPAN13 mRNA | CTD | PMID:25270620 | ozone | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in decreased expression of TSPAN13 mRNA and [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of TSPAN13 mRNA | CTD | PMID:34911549 | paracetamol | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of TSPAN13 mRNA | CTD | PMID:22230336 | paracetamol | affects response to substance | ISO | TSPAN13 (Homo sapiens) | 6480464 | TSPAN13 gene polymorphism affects the susceptibility to Acetaminophen | CTD | PMID:26104854 | phenobarbital | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Phenobarbital results in decreased expression of TSPAN13 mRNA | CTD | PMID:19482888 | phenobarbital | affects expression | ISO | Tspan13 (Mus musculus) | 6480464 | Phenobarbital affects the expression of TSPAN13 mRNA | CTD | PMID:23091169 | phenobarbital | affects expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of TSPAN13 mRNA | CTD | PMID:19159669 | phenobarbital | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of TSPAN13 mRNA] | CTD | PMID:19482888 | pirinixic acid | multiple interactions | ISO | Tspan13 (Mus musculus) | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of TSPAN13 mRNA | CTD | PMID:19710929 | potassium chromate | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | potassium chromate(VI) results in increased expression of TSPAN13 mRNA | CTD | PMID:22714537 | pravastatin | increases expression | EXP | | 6480464 | Pravastatin results in increased expression of TSPAN13 mRNA | CTD | PMID:27225895 | pravastatin | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Pravastatin results in increased expression of TSPAN13 mRNA | CTD | PMID:27225895 | progesterone | affects expression | ISO | Tspan13 (Mus musculus) | 6480464 | Progesterone affects the expression of TSPAN13 mRNA | CTD | PMID:17251523 | rotenone | decreases expression | EXP | | 6480464 | Rotenone results in decreased expression of TSPAN13 protein | CTD | PMID:35544339 | SB 431542 | multiple interactions | ISO | TSPAN13 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN13 mRNA | CTD | PMID:27188386 | silicon dioxide | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in decreased expression of TSPAN13 mRNA | CTD | PMID:25895662 | sodium arsenite | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of TSPAN13 mRNA | CTD | PMID:22714537 | sodium arsenite | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of TSPAN13 mRNA | CTD | PMID:37682722 | sodium arsenite | affects methylation | ISO | TSPAN13 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of TSPAN13 gene | CTD | PMID:28589171 | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of TSPAN13 mRNA | CTD | PMID:30047161 | temozolomide | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Temozolomide results in decreased expression of TSPAN13 mRNA | CTD | PMID:31758290 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of TSPAN13 mRNA | CTD | PMID:34492290 | titanium dioxide | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of TSPAN13 mRNA | CTD | PMID:27760801 | topotecan | affects response to substance | ISO | TSPAN13 (Homo sapiens) | 6480464 | TSPAN13 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | triadimefon | increases expression | EXP | | 6480464 | triadimefon results in increased expression of TSPAN13 mRNA | CTD | PMID:30047161 | trichloroethene | affects expression | ISO | Tspan13 (Mus musculus) | 6480464 | Trichloroethylene affects the expression of TSPAN13 mRNA | CTD | PMID:21135412 | trichostatin A | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of TSPAN13 mRNA | CTD | PMID:26272509 | trichostatin A | affects expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | trichostatin A affects the expression of TSPAN13 mRNA | CTD | PMID:28542535 | trichostatin A | multiple interactions | ISO | TSPAN13 (Homo sapiens) | 6480464 | [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of TSPAN13 mRNA | CTD | PMID:27188386 | triclosan | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of TSPAN13 mRNA | CTD | PMID:30510588 | trovafloxacin | decreases expression | ISO | Tspan13 (Mus musculus) | 6480464 | trovafloxacin results in decreased expression of TSPAN13 mRNA | CTD | PMID:35537566 | urethane | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Urethane results in increased expression of TSPAN13 mRNA | CTD | PMID:28818685 | valproic acid | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | Valproic Acid results in increased expression of TSPAN13 mRNA | CTD | PMID:21427059 | valproic acid | affects expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of TSPAN13 mRNA | CTD | PMID:25979313 | valproic acid | increases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of TSPAN13 mRNA | CTD | PMID:23179753 and PMID:29154799 | vincaleukoblastine | affects response to substance | ISO | TSPAN13 (Homo sapiens) | 6480464 | TSPAN13 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vinclozolin | increases expression | EXP | | 6480464 | vinclozolin results in increased expression of TSPAN13 mRNA | CTD | PMID:23034163 | zaragozic acid A | increases expression | ISO | Tspan13 (Mus musculus) | 6480464 | squalestatin 1 results in increased expression of TSPAN13 mRNA | CTD | PMID:27225895 | zaragozic acid A | increases expression | EXP | | 6480464 | squalestatin 1 results in increased expression of TSPAN13 mRNA | CTD | PMID:27225895 | zinc atom | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of TSPAN13 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | TSPAN13 (Homo sapiens) | 6480464 | Zinc deficiency results in decreased expression of TSPAN13 mRNA | CTD | PMID:22171008 | |